NCT01880788View on ClinicalTrials.gov

Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

CompletedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

August 31, 2015

Conditions
Age Related Macular DegenerationChoroidal NeovascularizationCentral Serous Chorioretinopathy
Trial Locations (1)

10022

Vitreous Retina Macula Consultants of New York, New York

All Listed Sponsors
collaborator

Vitreous -Retina- Macula Consultants of New York

OTHER

lead

Sequenom, Inc.

INDUSTRY

NCT01880788 - Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD | Biotech Hunter | Biotech Hunter